Showing results (131-140 of 145) with videos related to
Sort By:
Pageof 15
Journal of Affective Disorders|November 14, 2016
Amygdala and dlPFC abnormalities, with aberrant connectivity and habituation in response to emotional stimuli in females with BPDRobert B Dudas, Tom B Mole, Laurel S Morris, et al.The International Journal of Periodontics & Restorative Dentistry|August 18, 2018
Flapless Postextraction Socket Implant Placement: The Effects of a Platform Switch-Designed Implant on Peri-implant Soft Tissue Thickness-A Prospective StudyHanae Saito, Stephen J Chu, Jonathan Zamzok, et al.Clinical Trials (London, England)|June 22, 2021
Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United KingdomM Estée Török, Benjamin R Underwood, Mark Toshner, et al.Schizophrenia Research|June 24, 2011
Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal modelMargaret Hahn, Araba Chintoh, Adria Giacca, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2013
Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal modelMargaret K Hahn, Araba Chintoh, Gary Remington, et al.Psychopharmacology|June 3, 2016
Atypical antipsychotics and effects on feeding: from mice to menLouise Benarroch, Chantel Kowalchuk, Virginia Wilson, et al.The Lancet. Psychiatry|April 19, 2020
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health scienceEmily A Holmes, Rory C O'Connor, V Hugh Perry, et al.Journal of Hepatology|July 27, 2019
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis BNina Le Bert, Loghman Salimzadeh, Upkar Singh Gill, et al.Journal of Clinical Psychopharmacology|October 9, 2013
Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controlsMargaret Karolina Hahn, Tom M S Wolever, Tamara Arenovich, et al.Oral Diseases|December 28, 2021
Reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19Taísa Coelho Guimarães, Barbara Bruno Fagundes Marques, Marcelle Viana de Castro, et al.Pageof 15